When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Insuficiência cardíaca com fração de ejeção preservada

Última revisión: 15 Aug 2025
Última actualización: 08 Jan 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • presença de fatores de risco
  • dispneia por esforço
Todos los datos

Otros factores de diagnóstico

  • ortopneia
  • dispneia paroxística noturna
  • plenitude abdominal
  • estertores
  • estase jugular
  • refluxo hepatojugular
  • hepatomegalia congestiva
  • edema nos membros inferiores
  • impulso apical deslocado lateralmente
  • ritmos de galope
Todos los datos

Factores de riesgo

  • hipertensão
  • fibrilação atrial (FA)
  • sexo feminino
  • idade >70 anos
  • obesidade
  • doença arterial coronariana (DAC)/isquemia
  • diabetes mellitus
  • doença renal crônica (DRC)
  • dislipidemia
  • exposição a agentes cardiotóxicos
  • síndrome metabólica ou síndrome cardiovascular-renal-metabólica
  • distúrbios do miocárdio e pericárdio
  • apneia obstrutiva do sono
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • eletrólitos séricos
  • testes de função renal
  • enzimas hepáticas
  • peptídeo natriurético do tipo B (PNB)/fragmento N-terminal do peptídeo natriurético do tipo B (NT-proPNB)
  • Hemograma completo e perfil de ferro
  • eletrocardiograma (ECG) de 12 derivações
  • glicose sanguínea
  • testes da função tireoidiana
  • lipídeos séricos
  • radiografia torácica
  • ecocardiografia transtorácica
Todos los datos

Pruebas diagnósticas que deben considerarse

  • ressonância nuclear magnética cardíaca (RNMC)
  • Angiotomografia
  • ventriculografia com radionuclídeos (exame MUGA [angiografia sincronizada multinuclear])
  • teste ergométrico
  • teste ergométrico (CPET)
  • cateterismo cardíaco e angiografia coronariana
Todos los datos

Algoritmo de tratamiento

Agudo

todos os pacientes

Colaboradores

Autores

Syed Wamique Yusuf, FACC, FRCPI

Professor of Medicine

Department of Cardiology

University of Texas MD Anderson Cancer Center

Houston

TX

Divulgaciones

SWY declares that he has no competing interests.

Carl Zehner, MD

Assistant Professor of Medicine

Department of Cardiology

University of Texas MD Anderson Cancer Center

Houston

TX

Divulgaciones

CZ declares that he has no competing interests.

Agradecimientos

Dr Syed Wamique Yusuf and Dr Carl Zehner would like to gratefully acknowledge Dr Gerald Carr-White, Dr Jessica Webb, Dr Gerard Aurigemma, Dr Lokesh Tejwani, Dr Marc E. Del Rosario, and Dr Kul Aggarwal, previous contributors to this topic.

Divulgaciones

GCW has been reimbursed by Pfizer, AstraZeneca, Bayer, Medtronic, St Jude, and Sanofi for attending conferences. He has attended Advisory Boards for Medtronic, St Jude, Novartis, Shire, Sanofi, and Servier. JW has a joint working venture with BI for a community pharmacist post. GA, LT, MEDR, and KA declare that they have no competing interests.

Revisores por pares

Edward Geltman, MD

Professor of Medicine

Cardiovascular Division

Washington University School of Medicine

St. Louis

MO

Divulgaciones

EG has lectured for Novartis, Forest, Merck, and Pfizer.

Jerry Murphy, MB, BS, DM, FRCP

Consultant Cardiologist

Darlington Memorial Hospital

Darlington

UK

Divulgaciones

Not disclosed.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Bozkurt B, Coats AJ, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. 2021 Mar 1;S1071-9164(21)00050-6.Texto completo  Resumen

Kittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-78.Texto completo  Resumen

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022 May 3;145(18):e895-1032.Texto completo  Resumen

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-726.Texto completo

McDonagh TA, Metra M, Adamo M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Oct 1;44(37):3627-39.Texto completo  Resumen

Borlaug BA, Sharma K, Shah SJ, et al. Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol. 2023 May 9;81(18):1810-34. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Insuficiência cardíaca com fração de ejeção preservada images
  • Diferenciales

    • Insuficiência cardíaca com fração de ejeção reduzida
    • Amiloidose cardíaca
    • Cardiomiopatia hipertrófica (CMH)
    Más Diferenciales
  • 指南

    • 2024 ACC expert consensus decision pathway on clinical assessment, management, and trajectory of patients hospitalized with heart failure focused update: a report of the American College of Cardiology Solution Set Oversight Committee
    • ACR appropriateness criteria: suspected and known heart failure
    Más 指南
  • 患者教育信息

    Insuficiência cardíaca: como posso me ajudar?

    Insuficiência cardíaca

    更多 患者教育信息
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明